https://pubmed.ncbi.nlm.nih.gov/30168485/
S961, a biosynthetic insulin receptor antagonist, downregulates insulin receptor expression &...
IR antagonist, S961 showed distinct antagonism in vitro and appeared to be a powerful therapeutic modality that might provide insight into the pathogenesis of...
insulin receptorantagonistexpression